Navigation Links
MS Drug Tysabri Approved for Crohn's Disease
Date:1/14/2008

But the drug comes with serious risks, FDA notes

MONDAY, Jan. 14 (HealthDay News) -- Tysabri, a controversial drug used to treat multiple sclerosis, may also be used for patients with a moderate to severe form of another autoimmune illness, Crohn's disease, the U.S. Food and Drug Administration announced Monday.

But the drug also comes with a rare but serious risk of a potentially deadly brain infection, as well as other side effects, so it must be used carefully, the FDA said in a press teleconference.

"With the addition of Tysabri to the treatment options of sufferers of Crohn's disease, we make an important step in the armamentarium for treatment, but one that carries serious risks," said Dr. Joyce Korvick, deputy director of the division of gastroenterology products at the FDA's Office of New Drugs.

Crohn's is a serious, often painful, inflammatory bowel disorder that affects about 600,000 people in the United States. It can involve intestinal bleeding, diarrhea, weight loss, arthritis, skin problems, fever and anemia.

Tysabri (natalizumab), a monoclonal antibody used to treat MS, has been under a cloud of controversy for some time. The drug works by attaching itself to white blood cells called lymphocytes and preventing them from entering the brain, where they do damage that causes the disabling symptoms of MS.

But the drug has a checkered past. It first received U.S. Food and Drug Administration approval in November 2004, only to be pulled from the market three months later after several patients in clinical trials developed a rare but deadly viral infection of the brain called progressive multifocal leukoencephalopathy (PML).

In June 2006, the FDA allowed the drug to return to the market but with strict conditions. According to the new guidelines, Tysabri can only be administered by approved doctors, at infusion sites and pharmacies that register and comply with a patient-safety
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Stopping Tysabri May Worsen MS
2. Hiemstra Approved to Manufacture Medical Devices in New CER
3. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
4. Pennsylvania American Waters Rate Case Approved
5. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
6. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
7. A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
8. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
9. Optometry-Backed Vision Care for Kids Act Approved by U.S. House
10. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
11. FDA Cracks Down on Unapproved Cough Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MS Drug Tysabri Approved for Crohn's Disease
(Date:9/19/2014)... Top 10 Best SEO Hosting, ... HostGator.com, GoDaddy and Bluehost are among the best ... the most recommended suppliers for webmasters from the ... high quality Linux hosting (including VPS and cloud ... of many top hosting companies that started thinking ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Singulair, developed ... physiologic actions of leukotriene D4 (LTD4). LTD4 belongs to ... a variety of cells, including mast cells and eosinophils, ... Several studies have determined that there are higher concentrations ... compared with non-asthmatic individuals. The production of CysLTs is ...
(Date:9/19/2014)... September 19, 2014 Follow ... assays used for detection and quantification of the ... sample. Driven by steady expansion in immunodiagnostics and ... global immunoassay systems market has evolved remarkably well ... such as diabetes, cardio-vascular ailments, infectious diseases, allergy ...
(Date:9/19/2014)... MD & Salt Lake City, UT (PRWEB) September 19, ... to launch the new Activz Greens Smoothie ... Products Expo East, September 18th-20th in Baltimore, MD. ... with 8 organic super foods combined in one convenient ... Natural Products Expo East, September 18th-20th in Baltimore, MD. ...
(Date:9/19/2014)... grow well in infertile land, and bear many beans ... is because most legumes have a symbiotic relationship with ... air and then supply the host plant with ammonia ... organs called nodules in their roots. However, if too ... the growth of the plants, because the energy cost ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Long-distance communication from leaves to roots 2
... , , ... ANDS ) announced that it has entered into ... in gross proceeds in a "registered direct" offering through the ... estimates that net proceeds from the offering will be approximately ...
... , Supermarket Gains Latest Pharmacy Management Technology, Will Offer Patients ... Boise, Idaho-based Albertson,s, LLC has selected PDX and affiliates ... its pharmacy technology solution. , , Albertson,s, LLC ... Enterprise Pharmacy System (EPS), unparalleled in efficiency, ...
... vascular congestion is an important mediator in heart failure, ... Journal of Cardiac Failure ( http://www.onlinejcf.com/ ), ... that venous endothelium is a key regulator of central ... (HF). The present study demonstrates that in venous ...
... 4 Fora Care announces the launch of their ... their Point of Care Testing (POCT) System at the ... June 6-8 at the Ernest N. Morial Convention Center, ... patients to safely and securely upload critical blood glucose ...
... LONDON, June 4 The latest issue of ... authoritative,review on sulfonylureas by Professor Ian Campbell, a leading ... Professor Campbell,s review focuses on sulfonylurea-induced hypoglycemia,(SIH), which is ... 2 diabetes. In the review he discusses the incidence ...
... , SAN FRANCISCO, June 4 Medivation, Inc. (Nasdaq: ... and chief executive officer, will present at the 8th Annual ... a.m. Eastern Time at the New York Palace Hotel. , ... and its clinical development programs for Dimebon for Alzheimer,s and ...
Cached Medicine News:Health News:Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering 2Health News:Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering 3Health News:Albertson's, LLC Selects PDX-NHIN-Rx.com to Provide Complete Pharmacy Management Solution 2Health News:Fora Care Inc. to Launch Cost-Effective Solution for Diabetes Care at ADA 69th Scientific Sessions 2Health News:Comprehensive Review on Sulfonylureas in the Latest Issue of Diabetic Hypoglycemia (05 June 2009) 2Health News:Medivation to Present at 8th Annual Needham Life Sciences Conference 2
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) today reported ... 30, 2011, which reflect the Company,s continuing investment in the ... $202.7 million in cash and short-term investments, a decrease of ... 2011, the Company had a net loss of $27.4 million, ...
... The American College of Emergency Physicians, a national sponsor ... public about safe disposal of expired, unused and unwanted ... abuse or accidental overdose.  A recent study reports that ... deaths in 2008, more than half of the total ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Emergency Physicians Tell the Public,''Get Rid of Your Stash'' of Unwanted Meds on November 12th 2
MONOJECT Red/Yellow Mottled Stopper...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
BD Vacutainer® Specialty Tubes - Sedimentation Rate Determination (SRD)...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: